| Nome |
# |
|
Actors on the Scene: Immune Cells in the Myeloma Niche, file de3e52b5-2f60-762d-e053-3705fe0a30e0
|
39
|
|
Hydroxy-propil-β-cyclodextrin inclusion complexes of two biphenylnicotinamide derivatives: Formulation and anti-proliferative activity evaluation in pancreatic cancer cell models, file de3e52b5-2f5f-762d-e053-3705fe0a30e0
|
33
|
|
Cardiotoxicity Induced by Immune Checkpoint Inhibitors: What a Cardio-Oncology Team Should Know and Do, file 7c0fa5f8-93bc-4119-a090-734ec9fff0a5
|
31
|
|
NLRP3 Inflammasome From Bench to Bedside: New Perspectives for Triple Negative Breast Cancer, file de3e52b5-515b-762d-e053-3705fe0a30e0
|
27
|
|
Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside, file de3e52b5-2f58-762d-e053-3705fe0a30e0
|
24
|
|
FOLFIRINOX after first-line gemcitabine-based chemotherapy in advanced pancreatic cancer: a retrospective comparison with FOLFOX and FOLFIRI schedules, file de3e52b5-5f5c-762d-e053-3705fe0a30e0
|
24
|
|
Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial, file d607569b-bf1f-4245-ab33-b46b9f68cb99
|
22
|
|
The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib, file de3e52b5-2f63-762d-e053-3705fe0a30e0
|
22
|
|
The latest findings of PD-1/PD-L1 inhibitor application in gynecologic cancers, file de3e52b5-5160-762d-e053-3705fe0a30e0
|
17
|
|
Prognostic Role and Clinical Significance of Tumor-Infiltrating Lymphocyte (TIL) and Programmed Death Ligand 1 (PD-L1) Expression in Triple-Negative Breast Cancer (TNBC): A Systematic Review and Meta-Analysis Study, file de3e52b5-2df2-762d-e053-3705fe0a30e0
|
14
|
|
Bortezomib Treatment Modulates Autophagy in Multiple Myeloma, file de3e52b5-5f54-762d-e053-3705fe0a30e0
|
14
|
|
MiR-144: A new possible therapeutic target and diagnostic/prognostic tool in cancers, file de3e52b5-3688-762d-e053-3705fe0a30e0
|
13
|
|
Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study, file de3e52b5-2f51-762d-e053-3705fe0a30e0
|
12
|
|
COVID-19 Infection in Cancer Patients: How Can Oncologists Deal With These Patients?, file de3e52b5-5029-762d-e053-3705fe0a30e0
|
12
|
|
Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma, file de3e52b5-515c-762d-e053-3705fe0a30e0
|
12
|
|
Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples, file c4e2b84c-0588-4ff3-9299-278c18671b21
|
11
|
|
Current approaches for combination therapy of cancer: The role of immunogenic cell death, file de3e52b5-2f5a-762d-e053-3705fe0a30e0
|
11
|
|
On the Management of Drug Interactions in the Course of Concomitant Treatments for COVID-19 and Antineoplastic Agents, file de3e52b5-5161-762d-e053-3705fe0a30e0
|
11
|
|
Laparoscopic vs. open mesorectal excision for rectal cancer: Are these approaches still comparable? A systematic review and meta-analysis, file 03a3afab-dd55-43a5-a1df-497c146b53a4
|
10
|
|
Clinical meanings of rapid serological assay in patients tested for SARS-Co2 RT-PCR, file de3e52b5-30c4-762d-e053-3705fe0a30e0
|
10
|
|
Varied functions of immune checkpoints during cancer metastasis, file 65fa8aee-b04a-415a-bac7-6b1c72e43a3d
|
9
|
|
Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: An analysis from the Italian pharmacovigilance database, file b0530120-8b4c-4c3b-8603-72ba708a196b
|
9
|
|
Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials, file de3e52b5-2deb-762d-e053-3705fe0a30e0
|
9
|
|
COVID-19 pandemic and the crisis of health systems: The experience of the apulia cancer network and of the comprehensive cancer center Istituto tumori “Giovanni Paolo II” of Bari, file de3e52b5-2f4f-762d-e053-3705fe0a30e0
|
9
|
|
Rapid serological and SARS-CoV-2 RT-PCR assays: comparison performed simultaneously in symptomatic COVID-19 patients, file de3e52b5-5028-762d-e053-3705fe0a30e0
|
9
|
|
Moving the target on the optimal adjuvant strategy for resected pancreatic cancers: A systematic review with meta-analysis, file de3e52b5-5f56-762d-e053-3705fe0a30e0
|
8
|
|
Somatic BRCA Mutation in a Cholangiocarcinoma Patient for HBOC Syndrome Detection, file de3e52b5-30c5-762d-e053-3705fe0a30e0
|
7
|
|
Neutrophils, Crucial, or Harmful Immune Cells Involved in Coronavirus Infection: A Bioinformatics Study, file de3e52b5-5f5a-762d-e053-3705fe0a30e0
|
7
|
|
Rare histotypes of epithelial biliary tract tumors: A literature review, file a65e5192-dab6-4ce9-accc-daebaade94c3
|
6
|
|
Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paper, file 684ff4c7-1892-4b6e-b554-d4dc2a2b0b97
|
5
|
|
Basics and frontiers on pancreatic cancer for radiation oncology: Target delineation, SBRT, SIB technique, MRgRT, particle therapy, immunotherapy and clinical guidelines, file de3e52b5-60b9-762d-e053-3705fe0a30e0
|
5
|
|
mRNA-COVID19 Vaccination Can Be Considered Safe and Tolerable for Frail Patients, file 31099b8b-995d-4a63-bc60-ba974733e82a
|
4
|
|
A moonshot approach toward the management of cancer patients in the COVID-19 time: What have we learned and what could the Italian network of cancer centers (Alliance against Cancer, ACC) do after the pandemic wave?, file de3e52b5-30c3-762d-e053-3705fe0a30e0
|
4
|
|
The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer, file de3e52b5-5025-762d-e053-3705fe0a30e0
|
4
|
|
Clinical practice guidelines for diagnosis, treatment and follow-up of exocrine pancreatic ductal adenocarcinoma: Evidence evaluation and recommendations by the italian association of medical oncology (AIOM), file de3e52b5-60b6-762d-e053-3705fe0a30e0
|
4
|
|
Antineoplastic dosing in overweight and obese cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper, file 0434c4f9-8162-465f-b36e-d4b5df082f00
|
3
|
|
Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer, file de3e52b5-3689-762d-e053-3705fe0a30e0
|
3
|
|
Autophagic-Related Proteins in Brain Gliomas: Role, Mechanisms, and Targeting Agents, file c47791b8-de68-4de0-9e8a-4cae286dc94c
|
2
|
|
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial, file de3e52b5-2df0-762d-e053-3705fe0a30e0
|
2
|
|
A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery, file de3e52b5-2f50-762d-e053-3705fe0a30e0
|
2
|
|
Cytotoxic t-lymphocyte antigen-4 in colorectal cancer: Another therapeutic side of capecitabine, file de3e52b5-2f5b-762d-e053-3705fe0a30e0
|
2
|
|
The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead, file de3e52b5-5026-762d-e053-3705fe0a30e0
|
2
|
|
Biomarker phenotyping drives clinical management in axillary sentinel node: A retrospective study on women with primary breast cancer in 2002, file de3e52b5-515d-762d-e053-3705fe0a30e0
|
2
|
|
Validation of a Simple Scoring System to Predict Sorafenib Effectiveness in Patients with Hepatocellular Carcinoma, file de3e52b5-5f5d-762d-e053-3705fe0a30e0
|
2
|
|
Weighted gene co‐expression network analysis combined with machine learning validation to identify key modules and hub genes associated with sars‐cov‐2 infection, file de3e52b5-5f5e-762d-e053-3705fe0a30e0
|
2
|
|
Immune Checkpoint Inhibitors and the Kidney: A Focus on Diagnosis and Management for Personalised Medicine, file 10b1360f-d8ca-43b1-8c72-4742b0bea264
|
1
|
|
The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment, file 13acf560-e55a-4f39-9b83-7ebaa6e0fdfc
|
1
|
|
A Systematic Review on PD-1 Blockade and PD-1 Gene-Editing of CAR-T Cells for Glioma Therapy: From Deciphering to Personalized Medicine, file 3043ff0f-4b42-4256-9642-fc3529b7b8c7
|
1
|
|
Predictors of thyroid adverse events during cancer immunotherapy: a real-life experience at a single center, file 4e50161b-4082-4a65-b225-ed6d0e174951
|
1
|
|
Low and Ultra-Low HER2 in Human Breast Cancer: An Effort to Define New Neoplastic Subtypes, file 57103f00-cd1b-45e0-9a3b-fb4082106e87
|
1
|
|
The molecular profiling of solid tumors by liquid biopsy: a position paper of the AIOM-SIAPEC-IAP-SIBioC-SIC-SIF Italian Scientific Societies, file 68a87a08-20e6-4779-a736-285541b9581c
|
1
|
|
Expression and characterization of a novel recombinant cytotoxin II from Naja naja oxiana venom: A potential treatment for breast cancer, file 8950d4e8-bce3-4b0c-98f7-1d5db9d581f3
|
1
|
|
{PD}-L1 and Notch as novel biomarkers in Pancreatic Sarcomatoid Carcinoma: a pilot study, file de3e52b5-2de9-762d-e053-3705fe0a30e0
|
1
|
|
CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer, file de3e52b5-2dec-762d-e053-3705fe0a30e0
|
1
|
|
Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic Ductal Adenocarcinoma: A Pilot Study, file de3e52b5-2f52-762d-e053-3705fe0a30e0
|
1
|
|
The Genetic Germline Background of Single and Multiple Primary Melanomas, file de3e52b5-2f54-762d-e053-3705fe0a30e0
|
1
|
|
Arginase 1 (Arg1) as an Up-Regulated Gene in COVID-19 Patients: A Promising Marker in COVID-19 Immunopathy, file de3e52b5-2f59-762d-e053-3705fe0a30e0
|
1
|
|
A scoping review on the potentiality of PD-L1-inhibiting microRNAs in treating colorectal cancer: Toward single-cell sequencing-guided biocompatible-based delivery, file de3e52b5-2f5c-762d-e053-3705fe0a30e0
|
1
|
|
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview, file de3e52b5-2f61-762d-e053-3705fe0a30e0
|
1
|
|
Metabolic disorders and gastroenteropancreatic-neuroendocrine tumors (GEP-NETs): How do they influence each other? An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper, file de3e52b5-2f62-762d-e053-3705fe0a30e0
|
1
|
|
Hepatocellular Cancer, file de3e52b5-5022-762d-e053-3705fe0a30e0
|
1
|
|
Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib, file de3e52b5-5f55-762d-e053-3705fe0a30e0
|
1
|
|
Grape seed extracts modify the outcome of oxaliplatin in colon cancer cells by interfering with cellular mechanisms of drug cytotoxicity, file de3e52b5-5f58-762d-e053-3705fe0a30e0
|
1
|
|
Molecular characterization of a long-term survivor double metastatic non-small cell lung cancer and pancreatic ductal adenocarcinoma treated with gefitinib in combination with gemcitabine plus nab-paclitaxel and mFOLFOX6 as first and second line therapy, file de3e52b5-5f5b-762d-e053-3705fe0a30e0
|
1
|
|
Plasma-activated medium triggers cell death and the presentation of immune activating danger signals in melanoma and pancreatic cancer cells, file de3e52b5-5f5f-762d-e053-3705fe0a30e0
|
1
|
|
Strategies to improve cancer immune checkpoint inhibitors efficacy, other than abscopal effect: A systematic review, file de3e52b5-5f60-762d-e053-3705fe0a30e0
|
1
|
|
Immunotherapeutic approaches for hepatocellular carcinoma, file de3e52b5-60b7-762d-e053-3705fe0a30e0
|
1
|
|
Targeting angiogenesis in biliary tract cancers: An open option, file de3e52b5-60b8-762d-e053-3705fe0a30e0
|
1
|
| Totale |
513 |